Mechanistic basis for PI3K inhibitor antitumor activity and adverse reactions in advanced breast cancer Pamela R. DrullinskySara A. Hurvitz Review 09 April 2020 Pages: 233 - 248
Complete pathologic response rate to neoadjuvant chemotherapy increases with increasing HER2/CEP17 ratio in HER2 overexpressing breast cancer: analysis of the National Cancer Database (NCDB) Kathriena GreenwellLala HussainBarbara Wexelman Review 10 April 2020 Pages: 249 - 254
Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis Cameron B. HaasLarissa NekhlyudovKaren J. Wernli Review 17 April 2020 Pages: 255 - 268
Evaluation and management of insomnia in women with breast cancer Agnes KwakJamie JacobsJeffrey Peppercorn Review 20 April 2020 Pages: 269 - 277
Bone modifying agents for bone loss in patients with aromatase inhibitor as adjuvant treatment for breast cancer; insights from a network meta-analysis Hirotaka MiyashitaSera SatoiSe-Min Kim Review 21 April 2020 Pages: 279 - 289
Carbon ion radiation therapy in breast cancer: a new frontier Timothy D. MalouffAnita MahajanLaura A. Vallow Review 21 April 2020 Pages: 291 - 296
Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors Mary J. LawsYvonne ZieglerBenita S. Katzenellenbogen Preclinical study 10 April 2020 Pages: 297 - 307
Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response Mariko AsaokaSantosh K. PatnaikKazuaki Takabe Preclinical study 13 April 2020 Pages: 309 - 322
BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy Asuka KawachiSatoshi YamashitaKenji Tamura Preclinical study 20 April 2020 Pages: 323 - 329
FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer Tomoko HirakataTakaaki FujiiKen Shirabe Clinical trial 06 April 2020 Pages: 331 - 338
External validation of a prognostic model based on total tumor load of sentinel lymph node for early breast cancer patients Antonio Piñero-MadronaFrancisco Ripoll-OrtsVicente Peg-Cámara Clinical trial Open access 06 April 2020 Pages: 339 - 345
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy Karin RibiWeixiu LuoJürg Bernhard Clinical trial 09 April 2020 Pages: 347 - 359
Phyllodes tumors of the breast: a retrospective analysis of 57 cases Philou C. W. NoordmanNatasja M. KliouevaBart C. Vrouenraets Clinical trial 10 April 2020 Pages: 361 - 367
Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression Charlotte Levin Tykjær JørgensenCarina ForsareLisa Rydén Clinical trial Open access 16 April 2020 Pages: 369 - 381
Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning Heather A. JacenePamela J. DiPiroBeth Overmoyer Clinical trial 21 April 2020 Pages: 383 - 390
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence Tommy A. Brown IIElizabeth A. MittendorfGeorge E. Peoples Clinical trial Open access 22 April 2020 Pages: 391 - 401
Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis Tae-Kyung YooBong Joo KangByung Joo Chae Clinical trial 23 April 2020 Pages: 403 - 409
Association of body composition with function in women with early breast cancer G. F. P. AleixoA. M. DealS. S. Shachar Epidemiology 06 April 2020 Pages: 411 - 421
Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts Daniele GiardielloMichael HauptmannMarjanka K. Schmidt Epidemiology 11 April 2020 Pages: 423 - 434
Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China Jingfeng JingRan FengJinnan Gao Epidemiology 18 April 2020 Pages: 435 - 443
Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants Rinat Bernstein-MolhoEitan FriedmanYael Goldberg Epidemiology 18 April 2020 Pages: 445 - 453
Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials Dawn L. HershmanCathee TillJoseph M. Unger Epidemiology 18 April 2020 Pages: 455 - 463
Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women Chenjie ZengXingyi GuoWei Zheng Epidemiology Open access 21 April 2020 Pages: 465 - 473
Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study Mathilde GottschauSusanne K. KjærLene Mellemkjær Epidemiology 23 April 2020 Pages: 475 - 485
